Clinical trial condition

Shock

Explore clinical trials studying Shock. Study availability and eligibility vary by location and protocol.

1,179 public trials 225 recruiting studies

Refine in advanced search Browse all conditions

Shock trial results

Completed

The Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Trial

NCT03668236

Conditions: Infections, Inflammation, Pathologic Processes, +6 more
Locations: University Hospital Brussels (UZB) Brussels, Belgium

Medical Intensive Care Unit, Fakultni Nemocnice Pilsen, Czechia

Dept. of Anaesthesia and Intensive Care, Aalborg University Hospital, Denmark. Aalborg, Denmark

Dept of Intensive Care,Copenhagen University Hospital Rigshospitalet Copenhagen, Denmark

View all 31 locations

View Trial Details

Completed

Prospective Validation of the SHOCKMATRIX Hemorrhage Predictive Model

NCT06270615

Conditions: Hemorrhage, Hemorrhagic Shock, Pathologic Processes, +6 more
Locations: Beaujon Hospital AP-HP, Anesthesia-Intensive Care Department Clichy, France

Grenoble Alpes University Hospital La Tronche, France

Bicêtre Hospital AP-HP, Anesthesia-Intensive Care Department Le Kremlin-Bicêtre, France

Lille University Hospital, Anaesthesia and Intensive Care Unit Lille, France

View Trial Details

Completed

Registry for Hemoperfusion of Covid-19 ICU Patients

NCT05470907

Conditions: AKI - Acute Kidney Injury, Acute Kidney Injury, COVID-19 Acute Respiratory Distress Syndrome, +19 more
Locations: University Hospital Center Zagreb Zagreb, City of Zagreb, Croatia

View Trial Details

Completed

Intravenously Administered M6229 in Critically Ill Sepsis Patients

NCT05208112

Conditions: Critical Illness, Disease Attributes, Infections, +8 more
Locations: Maastricht UMC+ Maastricht, Limburg, Netherlands

Amsterdam UMC, location AMC Amsterdam, North Holland, Netherlands

View Trial Details

Completed

Facilitating Communication Study

NCT03721952

Conditions: Brain Diseases, Brain Injuries, Cardiovascular Diseases, +45 more
Locations: UW Medicine - Harborview Medical Center Seattle, Washington, United States

University of Washington Medical Center - Northwest Seattle, Washington, United States

University of Washington Medical Center - Montlake Seattle, Washington, United States

View Trial Details

Completed

The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock

NCT04325035

Conditions: Cardiogenic Shock, Cardiovascular Diseases, Heart Diseases, +11 more
Locations: Tufts Medical Center Boston, Massachusetts, United States

Hospital Italiano de Bueno Aires Capital Federal, Buenos Aires, Argentina

Santorio Guemes Capital Federal, Buenos Aires, Argentina

Hospital Privado de Rosario Rosario, Sante Fe, Argentina

View all 13 locations

View Trial Details

Completed

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

NCT04466098

Conditions: ARDS (Moderate or Severe), Acute Respiratory Distress Syndrome, COVID-19, +30 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Intravenous Metoprolol in Septic Shock

NCT06592547

Conditions: Cross Infection, Disease Attributes, Healthcare-Associated Pneumonia, +16 more
Locations: Alexandria Main university hospital Alexandria, Egypt

View Trial Details

Completed

The AT-REBOA Target Trial

NCT06312436

Conditions: Cardiac Arrest Due to Trauma, Hemorrhage, Multiple Trauma, +6 more
Locations: University Medical Centre Graz Graz, Styria, Austria

Center for Medical Data Science Vienna, Austria

View Trial Details

Completed

Citrulline and Arginase Activity in Severe Sepsis and Septic Shock

NCT03837730

Conditions: Biomarkers, Infection, Infections, +9 more
Locations: CHU de BESANCON Besançon, France

View Trial Details

Shock

Shock trial results

Related conditions